Under which condition may a company use prescriber data? (NOT permissible use)

Under which condition may a company use prescriber data? (NOT permissible use)

• A. Use data with patient identity omitted
• B. Use data to track adverse events of marketed prescription drugs
• C. Use data to focus marketing towards HCPs who would most likely benefit from the drug information
• D. Only use data if a physician has not requested that their data be made unavailable to sales representatives

Answer: (C)

The main idea here is how prescriber data can be used without crossing ethical and regulatory lines. Prescriber data can be used for non-promotional purposes, like informing safety communications or for broad, general educational outreach, and you should always respect a physician’s opt-out preferences. It’s also acceptable to use de-identified information to protect patient privacy, and to engage in pharmacovigilance activities such as tracking adverse events. The option that is not permissible is using prescriber data to tailor marketing narrowly to HCPs who would be most likely to benefit from the drug information. This kind of targeted promotional approach uses prescriber data to direct messages at specific individuals or groups based on their practice, which raises concerns about inappropriate influence and violates typical industry guidelines that discourage personalized promotion to individual prescribers. Other uses listed align with allowed practices, but this form of targeted promotional focus is the one not allowed.

The main idea here is how prescriber data can be used without crossing ethical and regulatory lines. Prescriber data can be used for non-promotional purposes, like informing safety communications or for broad, general educational outreach, and you should always respect a physician’s opt-out preferences. It’s also acceptable to use de-identified information to protect patient privacy, and to engage in pharmacovigilance activities such as tracking adverse events.

The option that is not permissible is using prescriber data to tailor marketing narrowly to HCPs who would be most likely to benefit from the drug information. This kind of targeted promotional approach uses prescriber data to direct messages at specific individuals or groups based on their practice, which raises concerns about inappropriate influence and violates typical industry guidelines that discourage personalized promotion to individual prescribers. Other uses listed align with allowed practices, but this form of targeted promotional focus is the one not allowed.